This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Osol, G. Articles by Weinberg, D. Search for Related Content PubMed PubMed Citation Articles by Osol, G. Articles by Weinberg, D.

Hypertension, Vol 8, 606-610, Copyright © 1986 by American Heart Association

ARTICLES

Synthetic atrial natriuretic factor does not dilate resistance-sized arteries

G Osol, W Halpern, B Tesfamariam, K Nakayama and D Weinberg

The effects of synthetic atrial natriuretic factor and atriopeptin III on induced tone in resistance-sized arteries from the rat were examined in vitro. Cylindrical segments of small mesenteric or cerebral arteries were mounted on a microcannula and pressurized to a transmural pressure of 75 mm Hg. After equilibration, the level of tone in cerebral arteries was on the order of - 35 change in diameter; addition of atrial natriuretic factor or atriopeptin III in cumulative doses from 10(-10) to 10(-7) M did not produce any transient or sustained changes in diameter. Similarly, atrial natriuretic factor or atriopeptin III did not alter the contractile responses of cerebral vessels to serotonin or prostaglandin F2 alpha. Mesenteric arteries, which do not possess an intrinsic myogenic tone, were precontracted with potassium (30 mM), norepinephrine (10(-6) M), or prostaglandin F2 alpha (1.1 X 10(-5) M) and exposed to the synthetic natriuretic peptides, also without effect. Transmural electrical stimulation (0.3-msec pulses; 180 mA; 4/second) relaxed cerebral and contracted mesenteric arteries; preincubation in 10(-7) M atrial natriuretic factor or atriopeptin III did not alter subsequent responses. These observations suggest that the hypotensive action of atrial natriuretic factor cannot be attributed to direct vasodilation of splanchnic or cerebral resistance-sized arteries.

This article has been cited by other articles:

				I. C. Villar, C. M. Panayiotou, A. Sheraz, M. Madhani, R. S. Scotland, M. Nobles, B. Kemp-Harper, A. Ahluwalia, and A. J. Hobbs Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor Cardiovasc Res, June 1, 2007; 74(3): 515 - 525. [Abstract] [Full Text] [PDF]

				M. Kuhn Structure, Regulation, and Function of Mammalian Membrane Guanylyl Cyclase Receptors, With a Focus on Guanylyl Cyclase-A Circ. Res., October 17, 2003; 93(8): 700 - 709. [Abstract] [Full Text] [PDF]

				R. Holtwick, M. Gotthardt, B. Skryabin, M. Steinmetz, R. Potthast, B. Zetsche, R. E. Hammer, J. Herz, and M. Kuhn Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure PNAS, May 14, 2002; 99(10): 7142 - 7147. [Abstract] [Full Text] [PDF]

				L. G. MELO, M. E. STEINHELPER, S. C. PANG, Y. TSE, and U. ACKERMANN ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models Physiol Genomics, June 29, 2000; 3(1): 45 - 58. [Abstract] [Full Text] [PDF]

				U. Ackermann and N. Azizi Increased central AT1-receptor activation, not systemic vasopressin, sustains hypertension in ANP knockout mice Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1441 - R1445. [Abstract] [Full Text] [PDF]

				L. G. Melo, A. T. Veress, U. Ackermann, M. E. Steinhelper, S. C. Pang, Y. Tse, and H. Sonnenberg Chronic regulation of arterial blood pressure in ANP transgenic and knockout mice: Role of cardiovascular sympathetic tone Cardiovasc Res, August 1, 1999; 43(2): 437 - 444. [Abstract] [Full Text] [PDF]

				L. G. Melo, A. T. Veress, U. Ackermann, and H. Sonnenberg Chronic regulation of arterial blood pressure by ANP: role of endogenous vasoactive endothelial factors Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1826 - H1833. [Abstract] [Full Text] [PDF]

				R. D. Deliva and U. Ackermann Atrial natriuretic peptide and mechanisms of cardiovascular control. Role of serotonergic receptors Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R711 - R717. [Abstract] [Full Text] [PDF]

				H. de Leon, M.-C. Bonhomme, G. Thibault, and R. Garcia Localization of Atrial Natriuretic Factor Receptors in the Mesenteric Arterial Bed : Comparison With Angiotensin II and Endothelin Receptors Circ. Res., July 1, 1995; 77(1): 64 - 72. [Abstract] [Full Text]